|
The clinical challenge of progressive myoclonus epilepsy.
Picamilon | Modafinil | Deprenyl | Piracetam
|
stroke
|
Pyritinol
|
benfotiamine
|
| Alzheimer's | |
| piracetam Alzheimer's study | |
| piracetam controlled study with dementia syndrome | |
| piracetam induced EEG changes in Alzheimer's | |
| piracetam effect on cerebral metabolism in Alzheimer's | |
| piracetam reverses hippocampal changes in Alzheimer's | |
| piracetam use in Alzheimer's | |
| piracetam effect on senile dementia memory | |
| Alcoholism | |
| piracetam alcoholic treatment | |
| piracetam efficacy in chronic alcoholics | |
| piracetam effect on alcoholics | |
| piracetam in acute alcohol withdrawal | |
| Brain injury | |
| piracetam effect on consciousness due to head injury | |
| piracetam protection in brain injury | |
| piracetam use in severe brain injury | |
| piracetam and concussion | |
| Circulatory disorders | |
| piracetam effectiveness in cerebral arteriosclerosis | |
| piracetam and chronic cerebrovascular disorders | |
| piracetam effect on brain circulation failure | |
| Deafness | |
| piracetam use in sudden deafness | |
| piracetam sudden hearing loss treatment | |
| piracetam in tinnitus and sudden deafness | |
| piracetam treatment of sudden deafness | |
| Dyslexia | |
| piracetam verbal effect in dyslexic boys | |
| piracetam efficacy in dyslexic reading and writing disorders | |
| piracetam improves reading in dyslexia | |
| piracetam learning aid in dyslexia | |
| piracetam effects on developmental dyslexia | |
| piracetam in students with dyslexia | |
| piracetam in children with dyslexia | |
| Heart Disease | |
| piracetam in ischemic heart disease | |
| piracetam effects on arterial hypertension | |
| piracetam effect on elderly coronary heart disease | |
| piracetam in chronic ischemic heart disease | |
| piracetam in ischemic heart disease | |
| piracetam in myocardial infarct patients | |
| Mental Function | |
| piracetam in patients with mental decline | |
| piracetam effects on cognitive functions | |
| piracetam efficacy in cognitive impairment | |
| piracetam in cerebral impairment | |
| piracetam study age-related memory disorders | |
| piracetam a trial on memory impairment | |
| piracetam interaction in the motor cortex | |
| piracetam effects on human EEG | |
| piracetam and EEG of boys with learning disorders | |
| piracetam effect on adolescent brain function | |
| piracetam in elderly cerebral impairment | |
| piracetam changes brain function | |
| piracetam effects on brain functions | |
| Stroke | |
| piracetam improves blood flow of post-stroke patients | |
| piracetam in secondary stroke prophylaxis | |
| piracetam treatment of acute and chronic aphasia | |
| piracetam in the treatment of acute stroke | |
| piracetam evaluation in acute stroke | |
| piracetam in stroke-unduced Aphasia | |
| piracetam treatment in ischemic stroke | |
| piracetam treatment of patients with an ischemic stroke | |
| piracetam acute stroke study | |
| piracetam effect on post-stroke recovery | |
| piracetam adjuvant to language therapy for aphasia | |
| piracetam effect on cerebral infarction in stroke patients | |
| Sickle cell disease | |
| piracetam treatment of children with sickle cell disease | |
| piracetam improves sickle cell deformability | |
| piracetam crises management of sickle cell disease | |
| Child birth | |
| piracetam in parturients and newborn infants | |
| piracetam reduced duration of labor | |
| piracetam protective effect during delivery | |
| piracetam concentrations during delivery | |
| Myoclonus | |
| piracetam promising results in myoclonus epilepsy | |
| piracetam long-term efficacy in myoclonus epilepsy | |
| piracetam beneficial use for severe myoclonus epilepsy | |
| piracetam and progressive myoclonus epilepsy | |
| piracetam in patients with myoclonus | |
| piracetam relieves symptoms in progressive myoclonus epilepsy | |
| piracetam in cortical myoclonus | |
| piracetam beneficial effect on post-ischaemic myoclonus | |
| Raynaud's | |
| piracetam treatment of Raynaud's | |
| piracetam evidence for its anti-platelet effect in Raynaud's | |
| piracetam platelet anti-aggregant properties | |
| Vertigo | |
| piracetam treatment for vertigo | |
| piracetam is effective in vertigo | |
| piracetam effect in 55 vertigo patients | |
| piracetam subjective improvement in vertigo | |
| piracetam significantly reduced vertigo symptoms | |
| Misc. | |
| piracetam efficacy in breath-holding spells | |
| piracetam mechanism of action | |
| piracetam elevates cholinergic receptor density | |
| piracetam cholinergic receptor function in mice | |
| piracetam effect on cerebral glucose utilization | |
| piracetam improved driving in elderly motorists | |
| piracetam and nootropics | |
| piracetam auxiliary treatment of cerebral palsy | |
| piracetam unique mode of action | |
| piracetam psychological and pharmacological treatment | |
| piracetam improves cholinergic system efficiency | |
| piracetam and vigilance | |
| piracetam versus acetylcholinesterase inhibitors | |
| piracetam therapy in recurrent duodenal ulcer | |
| piracetam efficacy in recurrence of duodenal ulcer | |
| piracetam treatment of soft tissue rheumatism | |
| piracetam effect on intellectually deficient children | |
| piracetam effect on neuroleptic-induced side effects | |
| piracetam improved school-performance in legasthenia | |
| piracetam effect on consciousness after neurosurgery | |
